European Organisation for Research and Treatment of Cancer - EORTC: Carcinoma, Non-Small-Cell Lung trials

The registry lists 20 Carcinoma, Non-Small-Cell Lung studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 13Phase 3 4No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain MetsNot yet recruitingNCT07234877Phase 2
• Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLCActive, not recruitingNCT06219317Phase 2
• Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC PatientsActive, not recruitingNCT04127110Phase 2
• Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)WithdrawnNCT03319316Phase 2
• Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.SuspendedNCT02470065Phase 2
• Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative ChemoStatus unknownNCT02273271Not applicable
• Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation StudyStatus unknownNCT01838577
• LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLCStatus unknownNCT01795521Phase 2
• Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by SurgeryTerminatedNCT00389688Phase 2
• Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00091156Phase 3
• High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNCT00062335Phase 1
• Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung CancerTerminatedNCT00021112Phase 2
• Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung CancerCompletedNCT00005868Phase 2
• Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00005055Phase 2
• Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00004151Phase 2
• ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaCompletedNCT00003989Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically RemovedTerminatedNCT00003803Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00003589Phase 3
• Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung CancerCompletedNCT00003062Phase 2
• Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00002623Phase 3